Related Experiment Videos
Alpha 1-antitrypsin genetic phenotypes in a group of children suffering from pulmonary diseases
Insights
This study identified Alpha 1-antitrypsin (AAT) variants in 10.2% of children with pulmonary diseases. Early detection of these AAT variants in young children may help identify future risks for chronic obstructive lung diseases.
Area of Science:
- Pulmonary Medicine
- Genetics
- Biochemistry
Background:
- Alpha 1-antitrypsin (AAT) is a key protease inhibitor in human serum.
- Pulmonary diseases in children can have long-term implications, including chronic obstructive lung diseases (COPD).
- Identifying genetic predispositions early is crucial for preventative care.
Purpose of the Study:
- To investigate the prevalence of Alpha 1-antitrypsin (AAT) genetic variants in children with pulmonary diseases.
- To assess the potential for early identification of individuals at risk for developing chronic obstructive lung diseases.
Main Methods:
- Studied 88 children diagnosed with various pulmonary diseases.
- Determined AAT genetic phenotypes using acid agarose gel electrophoresis.
- Confirmed phenotypes with crossed antigen-antibody electrophoresis in agarose gel.
Main Results:
- Identified AAT variants in 10.2% of the pediatric cohort.
- Observed AAT phenotypes included MZ (4.54%), MS (3.40%), and MM (89.77%).
- Rare variants FF and MV were also detected; all variants were found in children under 6 years old.
Conclusions:
- A significant proportion of children with pulmonary issues carry AAT variants.
- The presence of AAT variants in young children suggests a potential early marker for future lung disease risk.
- Further longitudinal studies are warranted to confirm the link between these variants and COPD development.
Abstract:
Alpha 1-antitrypsin (AAT), the main protease inhibitor of human sera, was studied in a group of 88 children suffering from different pulmonary diseases, with the hope that some of the potential victims of chronic obstructive lung diseases can be identified in time. AAT genetic phenotypes were determined using acid agarose gel electrophoresis, followed by crossed antigen-antibody electrophoresis in agarose gel. Identification of the banding patterns revealed 10.2% of AAT variants. 4.54% of the patients were MZ, 3.40% were MS and 89.77% were MM. During this study, 1 FF and 1 MV subject were also found. All AAT variants were in the group of younger children, under 6 years of age.